Draft US bill on payments to physicians imposes strict disclosure rules
This article was originally published in RAJ Devices
Senators Charles Grassley (Republican - Iowa) and Herb Kohl (Democrat - Wisconsin) have reintroduced legislation that seeks to impose strict rules for disclosing financial relationships between medical device companies and doctors, including requiring the creation of a national registry of industry payments to physicians1. The Physician Payments Sunshine Act now has a lower payment disclosure threshold - namely requiring drug and device companies to publicly report the payments, consulting fees, honoraria and other “transfers” they give to doctors over $100 every year. In the previous version of the bill (S 2029), the threshold was $5002. The information would be posted on a federal website for public viewing in 2011.
You may also be interested in...
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.